PCR | GenomeWeb


The firm postponed the launch to enhance Omni's capabilities, in the meantime focusing on opportunities in near-patient testing for its GeneXpert system.

The test was developed by Quest's Focus Diagnostics subsidiary and is the first from a commercial lab to receive an EUA.

Total revenues were $144.8 million, a 13 percent increase on a constant currency basis, and beating the average analysts' estimate of $140.2 million.

The UK-based firm plans to marry its core strengths with the probes and PCR platforms, and to build its sales force in the US. 

Infectious disease product revenues fell 25 percent year over year, while women's health and gastrointestinal sales were flat.

Fluid identification system and production and use thereof
System and method for determining copies-per-unit-volume using PCR and flow control of droplets
Cartridge for conducting a chemical reaction
Systems and methods for detecting the presence of a biological status using plot
Apparatus for thermal cycling